Predictors of intention to vaccinate against COVID-19: Results of a nationwide survey

Ruiz, Jeanette B.; Bell, Robert A.

doi:10.1016/j.vaccine.2021.01.010

Cited by 574 publications

(679 citation statements)

References 17 publications

Supporting

Mentioning

545

Contrasting

Unclassified

Order By: Relevance

“…Some online studies collected political party affiliation or conservative versus liberal attitudes to quantify the partisan impacts on pandemic response. 19,22,28,37,38 In general, White, Republicans, and conservatives were less likely to wear masks or practice social distancing. Fortunately, Dr. Anthony Fauci has become a household name and research suggests that his endorsement of wearing masks and COVID-19 vaccines increases confidence and uptake among Democrats and Republicans alike.…”

Section: Discussionmentioning

confidence: 99%

“…Unlike representative online panel studies, 17–28,35,36 we captured vast differences in COVID-19 vaccine hesitancy among historically marginalized populations living in areas that lack technology and reliable internet service. 33 The estimated prevalence of vaccine hesitancy in national studies ranged between ∼11% to 35% whereas in the ACCORD study, it ranged between 42% to 79% depending on the race/ethnicity and collection window.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

COVID-19 Vaccine Hesitancy in Underserved Communities of North Carolina

Doherty

Pilkington

Brown

et al. 2021

Preprint

View full text Add to dashboard Cite

Background: In the United States, underserved communities including Blacks and Latinx are disproportionately affected by COVID19, and widespread vaccination is critical for curbing this pandemic. This study sought to estimate the prevalence of COVID19 vaccine hesitancy, describe attitudes related to vaccination, and identify correlates among racial minority and marginalized populations across 9 counties in North Carolina. Methods: We conducted a cross-sectional survey with a self administered questionnaire distributed at free COVID19 testing events in underserved rural and urban communities from August 27 to December 15, 2020. Vaccine hesitancy was defined as the response of NO or DO NOT KNOW/NOT SURE to whether the participant would get the COVID19 vaccine as soon as it became available. Results: The sample comprised 948 participants including 27.7% Whites, 59.6% Blacks, 12.7% Latinx, and 63% female. Thirty-two percent earned <$20K annually, 60% owned a computer and ~80% had internet access at home. The prevalence of vaccine hesitancy was 68.9% including 62.7%, 74%, and 59.5% among Whites, Blacks, and Latinx, respectively. Between September and December, the largest decline in vaccine hesitancy occurred among Whites (27.5 percentage points), followed by Latinx (17.6) and the smallest decline was among Black respondents (12.0). 51.2% of the respondents reported vaccine safety concerns, 23.7% wanted others to get of the respondents reported they would trust health care providers with information about the COVID19 vaccine. Factors associated with hesitancy in multivariable logistic regression included being female (OR=1.90 95%CI[1.36, 2.64]), being Black (OR=1.68 [1.106 2.45]), calendar month (OR=0.76 [0.63, 0.92]), safety concerns (OR=4.28 [3.06, 5.97]), and government distrust (OR=3.57 [2.26, 5.63]). Conclusions: This study reached underserved minority populations in a number of different locations to investigate COVID19 vaccine hesitancy. We built on existing relationships and further engaged the community, stake holders and health department to provide free COVID19 testing. This direct approach permitted assessment of vaccine hesitancy (which was much higher than national estimates), distrust, and safety concerns.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

COVID-19 Vaccine Hesitancy in Underserved Communities of North Carolina

Doherty

Pilkington

Brown

et al. 2021

Preprint

View full text Add to dashboard Cite

show abstract

“…On the contrary, relying on TV information appeared to be a protective factor for VH. Interestingly, Ruiz et al identified the most and least protective channels associated with VH [45].…”

Section: Discussionmentioning

confidence: 99%

Would Parents Get Their Children Vaccinated Against SARS-CoV-2? Rate and Predictors of Vaccine Hesitancy According to a Survey over 5000 Families from Bologna, Italy

et al. 2021

View full text Add to dashboard Cite

In the near future, COVID-19 vaccine efficacy trials in larger cohorts may offer the possibility to implement child and adolescent vaccination. The opening of the vaccination for these strata may play a key role in order to limit virus circulation, infection spreading towards the most vulnerable subjects, and plan safe school reopening. Vaccine hesitancy (VH) could limit the ability to reach the coverage threshold required to ensure herd immunity. The aim of this study was to investigate the prevalence and determinants of VH among parents/guardians toward a potentially available COVID-19 vaccination for children and adolescents. An online survey was performed in parents/guardians of children aged <18 years old, living in Bologna. Overall, 5054 questionnaires were collected. A vast majority (60.4%) of the parents/guardians were inclined to vaccinate, while 29.6% were still considering the opportunity, and 9.9% were hesitant. Highest vaccine hesitancy rates were detected in female parents/guardians of children aged 6–10 years, ≤29 years old, with low educational level, relying on information found in the web/social media, and disliking mandatory vaccination policies. Although preliminary, these data could help in designing target strategies to implement adherence to a vaccination campaign, with special regard to web-based information.

show abstract

“…Again, trust is important -although vaccine hesitancy is generally lower among older adults, it is present in the older age groups and also among substitute decision makers (SDMs) and LTCF staff who engage with older persons with cognitive impairment, impacting decision-making capacity to make vaccination decisions. 57,58 It is also important to have open lines of communication with frailty stakeholders, such as non-governmental organizations and advocacy groups. 41,42,[59][60][61] Existing relationships, which geriatricians may already have established, are helpful.…”

Section: Program Implementation and Communicationmentioning

confidence: 99%

Considering Frailty in SARS-CoV-2 Vaccine Development: How Geriatricians Can Assist

Andrew¹,

Schmader²,

Rockwood³

et al. 2021

CIA

View full text Add to dashboard Cite

The COVID-19 pandemic has disproportionately impacted frail older adults, especially residents of long-term care (LTC) facilities. This has appropriately led to prioritization of frail older adults and LTC residents, and those who care for them, in the vaccination effort against COVID-19. Older adults have distinct immunological, clinical, and practical complexity, which can be understood through a lens of frailty. Even so, frailty has not been considered in studies of COVID-19 vaccines to date, leading to concerns that the vaccines have not been optimally tailored for and evaluated in this population even as vaccination programs are being implemented. This is an example of how vaccines are often not tested in Phase 1/2/3 clinical trials in the people most in need of protection. We argue that geriatricians, as frailty specialists, have much to contribute to the development, testing and implementation of COVID-19 vaccines in older adults. We discuss roles for geriatricians in ten stages of the vaccine development process, covering vaccine design, trial design, trial recruitment, establishment and interpretation of illness definitions, safety monitoring, consideration of relevant health measures such as frailty and function, analysis methods to account for frailty and differential vulnerability, contributions in regulatory and advisory roles, post-marketing surveillance, and program implementation and public health messaging. In presenting key recommendations pertinent to each stage, we hope to contribute to a dialogue on how to push the field of vaccinology to embrace the complexity of frailty. Making vaccines that can benefit frail older adults will benefit everyone in the fight against COVID-19.

show abstract

Predictors of intention to vaccinate against COVID-19: Results of a nationwide survey

Cited by 574 publications

References 17 publications

COVID-19 Vaccine Hesitancy in Underserved Communities of North Carolina

COVID-19 Vaccine Hesitancy in Underserved Communities of North Carolina

Would Parents Get Their Children Vaccinated Against SARS-CoV-2? Rate and Predictors of Vaccine Hesitancy According to a Survey over 5000 Families from Bologna, Italy

Considering Frailty in SARS-CoV-2 Vaccine Development: How Geriatricians Can Assist

Contact Info

Product

Resources

About